Your browser doesn't support javascript.
loading
Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.
Foldi, Julia; Kahn, Adriana; Silber, Andrea; Qing, Tao; Reisenbichler, Emily; Fischbach, Neal; Persico, Justin; Adelson, Kerin; Katoch, Anamika; Chagpar, Anees; Park, Tristen; Blanchard, Adam; Blenman, Kim; Rimm, David L; Pusztai, Lajos.
Afiliación
  • Foldi J; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Kahn A; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Silber A; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Qing T; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Reisenbichler E; Department of Pathology, Saint Louis University, St. Louis, Missouri.
  • Fischbach N; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Persico J; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Adelson K; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Katoch A; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Chagpar A; Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
  • Park T; Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
  • Blanchard A; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Blenman K; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
  • Rimm DL; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Pusztai L; Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut.
Clin Cancer Res ; 28(17): 3720-3728, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35903931
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article